Cargando…
GSK-J4 induces cell cycle arrest and apoptosis via ER stress and the synergism between GSK-J4 and decitabine in acute myeloid leukemia KG-1a cells
BACKGROUND: GSK-J4 is the inhibitor of H3K27me3 demethylase. Recent studies demonstrated that GSK-J4 could affect the proliferation and apoptosis of a variety of cancer cells. However, the effects and underlying mechanisms of GSK-J4 on the proliferation and apoptosis of human acute myeloid leukemia...
Autores principales: | Chu, Xuan, Zhong, Liang, Yu, Lihua, Xiong, Ling, Li, Jian, Dan, Wenran, Ye, Jiao, Liu, Chen, Luo, Xu, Liu, Beizhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268296/ https://www.ncbi.nlm.nih.gov/pubmed/32514253 http://dx.doi.org/10.1186/s12935-020-01297-6 |
Ejemplares similares
-
RIP1-dependent Apoptosis and Differentiation Regulated by Skp2 and Akt/GSK3β in Acute Myeloid Leukemia
por: Dan, Wenran, et al.
Publicado: (2022) -
GSK-J4-Mediated Transcriptomic Alterations in Differentiating Embryoid Bodies
por: Mandal, Chanchal, et al.
Publicado: (2017) -
Synergy of GSK-J4 With Doxorubicin in KRAS-Mutant Anaplastic Thyroid Cancer
por: Lin, Bo, et al.
Publicado: (2020) -
The pharmacological role of histone demethylase JMJD3 inhibitor GSK-J4 on glioma cells
por: Sui, Aixia, et al.
Publicado: (2017) -
GSK3β mediates pancreatic cancer cell invasion in vitro via the CXCR4/MMP-2 Pathway
por: Ying, Xu, et al.
Publicado: (2015)